Fibrotic myofibroblasts manifest genome-wide derangements of translational control.

ABSTRACT:

Background

As a group, fibroproliferative disorders of the lung, liver, kidney, heart, vasculature and integument are common, progressive and refractory to therapy. They can emerge following toxic insults, but are frequently idiopathic. Their enigmatic propensity to resist therapy and progress to organ failure has focused attention on the myofibroblast-the primary effector of the fibroproliferative response. We have recently shown that aberrant beta 1 integrin signaling in fibrotic fibroblasts results in defective PTEN function, unrestrained Akt signaling and subsequent activation of the translation initiation machinery. How this pathological integrin signaling alters the gene expression pathway has not been elucidated.

Results

Using a systems approach to study this question

SUBMITTER: Larsson O 

PROVIDER: S-EPMC2528966 | biostudies-literature | 2008 Sep

REPOSITORIES: biostudies-literature